Artelon® Tissue Reinforcement - Reconstruction of a resected Achilles tendon

"The use of a gastrocnemius graft, reinforced with Artelon® Tissue Reinforcement, was highly successful. The graft operation had created a tendon that was virtually normal at the second operation one year after the initial procedure"

Jan Lidström M.D.Ph.D Senior Consultant Orthopedic Surgeon, Department of Orthopedic Surgery, Sahlgrenska University Hospital, Mölndal, Sweden.

Artelon® Tissue Reinforcement - Repair of Achilles tendon re-rupture

"Artelon® Tissue Reinforcement is well suited for secondary repair of a neglected rupture or rerupture of the Achilles tendon. The procedure also makes an extended incision and problems at the harvest site for the usual gastrocnemius graft unnecessary. This also reduces the risk of postoperative infection."

Artelon® Tissue Reinforcement - Repair of chronic Achilles tendon rupture

"The use of Artelon® Tissue Reinforcement to unload and bridge a chronic rupture of the Achilles tendon in order to restore the function of the foot for a patient with years of Achilles tendon pain seems to be a useful method."

Artelon® Tissue Reinforcement - Rotator cuff injury repair

"An elderly, hypertensive female diabetic presented with a large to massive rotator cuff tear, resulting in significant weakness and who had experienced multiple falls and injuries, even post-op. She was operated on and treated with Artelon® Tissue Reinforcement. Nine months after surgery, she continue to perform her normal daily activities and is comfortable using her arm at or below shoulder height."

Thomas A. Marberry, MD, Tulsa Bone & Joint Associates, Tulsa, OK, USA

Artelon® CMC Spacer - Outcomes with Artelon® CMC Spacer in thumb base osteoarthritis – a prospective 3-year follow-up with objective and subjective evaluation of function in daily life activities in 16 patients

"On average, the patients had regained their pinch strength after 1 year. A signifi cant increase in pinch strength was seen after 3 years, with significantly less pain (VAS) at maximal loading. Moderate to very large limitations in selected daily life activities before treatment were reported as none or mild in >50% of the patients after 1 year, and in around 70% after 3 years."

Sten Björnum, MD, Gothenburg Medical Center, Gothenburg, Sweden

Read more >>